Number of included patients WARD Medical RCT (n=300) 100% WARD Surgery RCT (n=400) 100% WARD Surgery RCT II (n=504) 100% WARD glucose validation (N=60) 100% WARD Glucose RCT (N=200) 87% WARD Home II (n=120) 72% WARD Fase 1 (N=100) 33% WARD Prospective study (n=3095) 19% [Updated 12-12-2025]